List of Tables
Table 1. Global Gabapentin Enacarbil Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gabapentin Enacarbil Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gabapentin Enacarbil Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gabapentin Enacarbil Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gabapentin Enacarbil Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gabapentin Enacarbil Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gabapentin Enacarbil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gabapentin Enacarbil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabapentin Enacarbil, Product Type & Application
Table 12. Global Key Manufacturers of Gabapentin Enacarbil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabapentin Enacarbil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabapentin Enacarbil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gabapentin Enacarbil Sales by Region (2020-2025) & (K Units)
Table 18. Global Gabapentin Enacarbil Sales Market Share by Region (2020-2025)
Table 19. Global Gabapentin Enacarbil Sales by Region (2026-2031) & (K Units)
Table 20. Global Gabapentin Enacarbil Sales Market Share by Region (2026-2031)
Table 21. Global Gabapentin Enacarbil Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gabapentin Enacarbil Revenue Market Share by Region (2020-2025)
Table 23. Global Gabapentin Enacarbil Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gabapentin Enacarbil Revenue Market Share by Region (2026-2031)
Table 25. North America Gabapentin Enacarbil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gabapentin Enacarbil Sales by Country (2020-2025) & (K Units)
Table 27. North America Gabapentin Enacarbil Sales by Country (2026-2031) & (K Units)
Table 28. North America Gabapentin Enacarbil Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gabapentin Enacarbil Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gabapentin Enacarbil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gabapentin Enacarbil Sales by Country (2020-2025) & (K Units)
Table 32. Europe Gabapentin Enacarbil Sales by Country (2026-2031) & (K Units)
Table 33. Europe Gabapentin Enacarbil Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gabapentin Enacarbil Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gabapentin Enacarbil Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gabapentin Enacarbil Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Gabapentin Enacarbil Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Gabapentin Enacarbil Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gabapentin Enacarbil Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gabapentin Enacarbil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gabapentin Enacarbil Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Gabapentin Enacarbil Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Gabapentin Enacarbil Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gabapentin Enacarbil Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gabapentin Enacarbil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gabapentin Enacarbil Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Gabapentin Enacarbil Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gabapentin Enacarbil Sales (K Units) by Type (2020-2025)
Table 51. Global Gabapentin Enacarbil Sales (K Units) by Type (2026-2031)
Table 52. Global Gabapentin Enacarbil Sales Market Share by Type (2020-2025)
Table 53. Global Gabapentin Enacarbil Sales Market Share by Type (2026-2031)
Table 54. Global Gabapentin Enacarbil Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gabapentin Enacarbil Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gabapentin Enacarbil Revenue Market Share by Type (2020-2025)
Table 57. Global Gabapentin Enacarbil Revenue Market Share by Type (2026-2031)
Table 58. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2020-2025)
Table 59. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2026-2031)
Table 60. Global Gabapentin Enacarbil Sales (K Units) by Application (2020-2025)
Table 61. Global Gabapentin Enacarbil Sales (K Units) by Application (2026-2031)
Table 62. Global Gabapentin Enacarbil Sales Market Share by Application (2020-2025)
Table 63. Global Gabapentin Enacarbil Sales Market Share by Application (2026-2031)
Table 64. Global Gabapentin Enacarbil Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gabapentin Enacarbil Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gabapentin Enacarbil Revenue Market Share by Application (2020-2025)
Table 67. Global Gabapentin Enacarbil Revenue Market Share by Application (2026-2031)
Table 68. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2020-2025)
Table 69. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2026-2031)
Table 70. Arbor Pharma Company Information
Table 71. Arbor Pharma Description and Business Overview
Table 72. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Arbor Pharma Gabapentin Enacarbil Product
Table 74. Arbor Pharma Recent Developments/Updates
Table 75. Astellas Company Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Astellas Gabapentin Enacarbil Product
Table 79. Astellas Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Gabapentin Enacarbil Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Glenmark Pharma Company Information
Table 86. Glenmark Pharma Description and Business Overview
Table 87. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Glenmark Pharma Gabapentin Enacarbil Product
Table 89. Glenmark Pharma Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Gabapentin Enacarbil Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Depomed Company Information
Table 96. Depomed Description and Business Overview
Table 97. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Depomed Gabapentin Enacarbil Product
Table 99. Depomed Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Gabapentin Enacarbil Product
Table 104. Teva Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mylan Gabapentin Enacarbil Product
Table 109. Mylan Recent Developments/Updates
Table 110. Novartis Company Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novartis Gabapentin Enacarbil Product
Table 114. Novartis Recent Developments/Updates
Table 115. Apotex Company Information
Table 116. Apotex Description and Business Overview
Table 117. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Apotex Gabapentin Enacarbil Product
Table 119. Apotex Recent Developments/Updates
Table 120. Sun Pharmaceutical Company Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sun Pharmaceutical Gabapentin Enacarbil Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Company Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Aurobindo Pharma Gabapentin Enacarbil Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Intas Company Information
Table 131. Intas Description and Business Overview
Table 132. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Intas Gabapentin Enacarbil Product
Table 134. Intas Recent Developments/Updates
Table 135. Amneal Company Information
Table 136. Amneal Description and Business Overview
Table 137. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Amneal Gabapentin Enacarbil Product
Table 139. Amneal Recent Developments/Updates
Table 140. Marksans Pharma Company Information
Table 141. Marksans Pharma Description and Business Overview
Table 142. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Marksans Pharma Gabapentin Enacarbil Product
Table 144. Marksans Pharma Recent Developments/Updates
Table 145. Alkem Company Information
Table 146. Alkem Description and Business Overview
Table 147. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Alkem Gabapentin Enacarbil Product
Table 149. Alkem Recent Developments/Updates
Table 150. Jiangsu Enhua Company Information
Table 151. Jiangsu Enhua Description and Business Overview
Table 152. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Jiangsu Enhua Gabapentin Enacarbil Product
Table 154. Jiangsu Enhua Recent Developments/Updates
Table 155. Jiangsu Hengrui Company Information
Table 156. Jiangsu Hengrui Description and Business Overview
Table 157. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Jiangsu Hengrui Gabapentin Enacarbil Product
Table 159. Jiangsu Hengrui Recent Developments/Updates
Table 160. Sailike Pharma Company Information
Table 161. Sailike Pharma Description and Business Overview
Table 162. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Sailike Pharma Gabapentin Enacarbil Product
Table 164. Sailike Pharma Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Gabapentin Enacarbil Distributors List
Table 168. Gabapentin Enacarbil Customers List
Table 169. Gabapentin Enacarbil Market Trends
Table 170. Gabapentin Enacarbil Market Drivers
Table 171. Gabapentin Enacarbil Market Challenges
Table 172. Gabapentin Enacarbil Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gabapentin Enacarbil
Figure 2. Global Gabapentin Enacarbil Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gabapentin Enacarbil Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Gabapentin Enacarbil Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Gabapentin Enacarbil Market Share by Application: 2024 & 2031
Figure 8. Post-Herpetic Neuralgia (PHN)
Figure 9. Restless Legs Syndrome (RLS)
Figure 10. Others
Figure 11. Global Gabapentin Enacarbil Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gabapentin Enacarbil Market Size (2020-2031) & (US$ Million)
Figure 13. Global Gabapentin Enacarbil Sales (2020-2031) & (K Units)
Figure 14. Global Gabapentin Enacarbil Average Price (US$/Unit) & (2020-2031)
Figure 15. Gabapentin Enacarbil Report Years Considered
Figure 16. Gabapentin Enacarbil Sales Share by Manufacturers in 2024
Figure 17. Global Gabapentin Enacarbil Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Gabapentin Enacarbil Players: Market Share by Revenue in Gabapentin Enacarbil in 2024
Figure 19. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Gabapentin Enacarbil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Gabapentin Enacarbil Sales Market Share by Country (2020-2031)
Figure 22. North America Gabapentin Enacarbil Revenue Market Share by Country (2020-2031)
Figure 23. United States Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Gabapentin Enacarbil Sales Market Share by Country (2020-2031)
Figure 26. Europe Gabapentin Enacarbil Revenue Market Share by Country (2020-2031)
Figure 27. Germany Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Gabapentin Enacarbil Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Region (2020-2031)
Figure 34. China Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Gabapentin Enacarbil Sales Market Share by Country (2020-2031)
Figure 44. Latin America Gabapentin Enacarbil Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Gabapentin Enacarbil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Gabapentin Enacarbil by Type (2020-2031)
Figure 54. Global Revenue Market Share of Gabapentin Enacarbil by Type (2020-2031)
Figure 55. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Gabapentin Enacarbil by Application (2020-2031)
Figure 57. Global Revenue Market Share of Gabapentin Enacarbil by Application (2020-2031)
Figure 58. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2020-2031)
Figure 59. Gabapentin Enacarbil Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
